SHOCKING: Abpi | Mind Blowing Facts

Dozens of MPs oppose Streeting’s new power to say what NHS pays for drugs

Health secretary’s ‘power grab’ to override Nice comes amid growing concern move may be illegal and benefit big pharma

The Guardian - UK · Apr 26

HRT maker censured by UK regulator for ‘systemic failures’ that put patients at risk

Drug industry’s self-regulatory body criticises Theramex, producer of Evorel and Intrarosa, for ‘alarming’ breaches

The Guardian - UK · Apr 22

Pharma giant ditches £1bn London research hub and says UK ‘is not internationally competitive’

Merck, known as MSD in Europe, criticised the UK’s business environment despite the government saying it has become ‘the most attractive place to invest in the world’

The Independent UK · Sep 11, 2025

Offer to increase UK spending on medicines shelved, Government says

Officials launched a review of the voluntary scheme for branded medicines pricing, access and growth earlier this year.

Evening Standard · Aug 22, 2025

Clinical trial hubs to open as part of £400m public-private investment

The 18 new Commercial Research Delivery Centres are intended to bolster the UK’s trials infrastructure and support the recruitment of patients.

The Independent UK · Aug 28, 2024

‘It’s naive to think this is in the best interests of the NHS.’ How Big Pharma’s millions are influencing healthcare

Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest

The Guardian - UK · Jul 8, 2023

Plunge in clinical drug trials makes Britain an urgent case for treatment

With visions of the UK as a ‘life sciences superpower’ at risk, we report from Great Ormond Street hospital on what’s being done to give children access to new drugs

The Guardian - UK · May 13, 2023

Revealed: maker of Wegovy ‘skinny jab’ is funding NHS weight-loss services

Critics fear conflict of interest as Novo Nordisk helps medics ‘reduce unnecessary barriers’ to treatment for obesity

The Guardian - UK · Apr 2, 2023

‘Skinny jab’ drug firm facing fresh inquiries after ‘serious breaches’ of industry code

Pharmaceutical company behind blockbuster diet jab Wegovy confronts crises on multiple fronts, amid scrutiny of UK activities

The Guardian - UK · Mar 18, 2023

Firm behind Wegovy slimming jab suspended from UK trade association

Novo Nordisk found to be in breach of ABPI code of practice over sponsored weight-loss courses that promoted its medicines

The Guardian - UK · Mar 16, 2023